| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |